Stock listing
NASDAQ:ALPN Alpine Immune Sciences Inc Stock
Follow Alpine Immune Sciences Inc into a list and get an email when it puts out news.
Last close · NASDAQ:ALPN
$64.97 USD
Close on May 17, 2024 · No longer trades
- Lowest – highest close
- $2.15 – $64.97 USDSince Jul 25, 2017 · lowest Mar 17, 2020 · highest May 15, 2024
Delisted NASDAQ:ALPN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:ALPN
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Alpine Immune Sciences Inc on 6ix
- Calls
- 6 calls with a replay · 6 with a transcript · latest May 6, 2024
- Decks
- 3 decks · latest Aug 9, 2022
Events
| Call | When | Status |
|---|---|---|
| Alpine Immune Sciences (ALPN) Q1 2024 Earnings Call | Mon, May 06, 2024 · 4:30 PM ET | Replay |
| Alpine Immune Sciences (ALPN) Q4 2023 Earnings Call | Mon, Mar 18, 2024 · 4:30 PM ET | Replay |
| Alpine Immune Sciences (ALPN) Q4 2022 Earnings Call | Thu, Mar 23, 2023 · 4:30 PM ET | Replay |
| Alpine Immune Sciences (ALPN) Q3 2022 Earnings Call | Mon, Nov 14, 2022 · 4:30 PM ET | Replay |
| Alpine Immune Sciences (ALPN) Q2 2021 Earnings Call | Tue, Aug 10, 2021 · 4:30 PM ET | Replay |
| Alpine Immune Sciences (ALPN) Q4 2020 Earnings Call | Thu, Mar 18, 2021 · 4:30 PM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (August 2022) | Investor deck | 39 slides | Aug 9, 2022 |
| Investor Presentation (September 2018) | Investor deck | 27 slides | Sep 25, 2018 |
| Nivalis Therapeutics — Technical Presentation (November 2016) | Technical | 16 slides | Nov 28, 2016 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| James N Topper Other companies: Attovia Therapeutics, Inc. (Director · Since at least Aug 4, 2026); NewAmsterdam Pharma Company N.V. (Director · Since at least Dec 29, 2023); Phathom Pharmaceuticals, Inc. (Director · Since at least Oct 24, 2019); Frazier Lifesciences Acquisition Corp (Chief Executive Officer, Director · Dec 8, 2020 – Dec 11, 2020 · Past); Entasis Therapeutics Holdings Inc (Director · Sep 25, 2018 – Jan 18, 2019 · Past); Aptinyx Inc (Director · Jun 20, 2018 – Mar 31, 2020 · Past); Allena Pharmaceuticals Inc (Director · Nov 1, 2017 – Nov 17, 2020 · Past); AnaptysBio, Inc. (Director · Jan 25, 2017 – Jan 6, 2023 · Past); Sierra Oncology Inc (Director · Jul 15, 2015 – Feb 14, 2017 · Past); Portola Pharmaceuticals Inc (Director · May 21, 2013 – Jun 5, 2013 · Past); Amicus Therapeutics Inc (Director · Jun 15, 2010 – Jun 12, 2014 · Past) | Director · Jul 24, 2017 – May 18, 2024 · Past |
| Cynthia Smith Other companies: Tvardi Therapeutics, Inc. (Board Member · Since at least Apr 15, 2025); Agios Pharmaceuticals, Inc. (Independent Director · Since at least Aug 11, 2022); Protara Therapeutics, Inc. (Director · Since at least Jan 29, 2021); Spero Therapeutics, Inc. (Director · Since at least Mar 19, 2019); Akebia Therapeutics, Inc. (Senior Vice President, Market Access and Commercial Development · Since at least Aug 28, 2018); Dicerna Pharmaceuticals Inc (Director · Aug 13, 2018 – Dec 28, 2021 · Past); ZS Pharma Inc (Chief Commercial Officer · Jun 17, 2014 – Dec 17, 2015 · Past) | Director · Nov 1, 2016 – Nov 1, 2016 · Past |
| Paul Sekhri Other companies: Apnimed, Inc. (Director · Since at least Jul 30, 2026); vTv Therapeutics Inc. (Chairman of the Board, President and Chief Executive Officer · Since at least Aug 1, 2022); Veeva Systems Inc. (Director · Since at least Jun 22, 2016); Axcella Health Inc (Director · May 19, 2022 – May 19, 2022 · Past); Longboard Pharmaceuticals Inc (Director · Mar 11, 2021 – Dec 2, 2024 · Past); BiomX Inc. (Director · Oct 2, 2020 – Jul 28, 2021 · Past); Enumeral Biomedical Holdings Inc (Director · Dec 9, 2016 – Dec 9, 2016 · Past) | Director · Sep 12, 2016 – Jan 2, 2020 · Past |
| Jonathan Leff Other companies: Larimar Therapeutics, Inc. (Director · Since at least May 28, 2020); BiomX Inc. (Director · Mar 15, 2024 – Apr 14, 2025 · Past); ARS Pharmaceuticals, Inc. (Director · Nov 8, 2022 – Nov 8, 2022 · Past); Protara Therapeutics, Inc. (Director · Aug 2, 2017 – Jun 8, 2018 · Past); AveXis Inc (Director · Feb 10, 2016 – Feb 10, 2016 · Past) | Director · Jun 16, 2015 – Sep 11, 2015 · Past |
| Christopher Peetz Other companies: Arcutis Biotherapeutics, Inc. (Director · Since at least Jul 15, 2026); Mirum Pharmaceuticals, Inc. (CHIEF EXECUTIVE OFFICER, Director · Since at least Jul 17, 2019) | Director · Apr 20, 2018 – May 20, 2024 · Past |
| James Paul Rickey Other companies: Braveheart Bio, Inc. (Chief Financial Officer · Since at least Aug 5, 2026); Immune Design Corp (VP, Finance and Administration · Jul 23, 2014 – Jan 7, 2015 · Past) | See Remarks · Jul 24, 2017 – May 20, 2024 · Past |
| Jay Venkatesan Other companies: Serina Therapeutics, Inc. (Director · Since at least Feb 12, 2025); Elicio Therapeutics, Inc. (Director · Since at least May 20, 2022) | Director · Jul 15, 2022 – Jul 15, 2022 · Past |
| David Malcom Rodman Other companies: Mineralys Therapeutics, Inc. (Chief Medical Officer · Since at least Feb 9, 2023) | Exec Vice President and CMO · Apr 18, 2016 – Jan 3, 2017 · Past |
| Robert E Conway Other companies: Oruka Therapeutics, Inc. (Director · Sep 3, 2013 – Jan 30, 2024 · Past) | Director · Jun 16, 2015 – May 20, 2024 · Past |
| Ulrich Martin Fuhs | Chief Accounting Officer · Apr 3, 2024 – May 20, 2024 · Past |
Log in to ask 6ix AI your own questions about Alpine Immune Sciences Inc.